Recently, DSHB expanded into microbial research, providing deeply discounted monoclonal antibodies and hybridomas.
Recently, the difficulty in microbial research has been overcome with the development of SCS.
Particular caution needs to be taken in the context of clinical applications of microbial research.
Due to the sensitive nature of microbial data (both clinical and genetic), risks arising in microbial research may lead to negative consequences for participants regarding privacy breaches.
In human microbial research, these issues "becomes more complicated as the validity, reliability, relevance, and clinical significance of human microbial data are largely uncertain" (Ma et al., 2017).
But there is also hype sometimes mixed with hope, which is dangerous and risky, and may discredit the value of microbial research in the long run.
In this review, we focus on recent developments offered by the rapid advances in AFM imaging and force spectroscopy with emphasizes on microbial research.
With the increasing availability of complete microbial genomes, DNA microarrays are becoming a common tool in many areas of microbial research, including microbial physiology, pathogenesis, epidemiology, ecology, phylogeny, pathway engineering and fermentation optimization.
This collaboration involves HHMI, a not-for-profit medical research organization with a $14 billion endowment, teaming with the Gordon and Betty Moore Foundation, a philanthropy based in Palo Alto, California, that is best known for supporting environmental conservation and, more recently, microbial research.
